Pfizer's four business units may be combined into two, a top company official said, triggering speculation by analysts that the world's biggest drugmaker is preparing to split in half.
Pfizer's possible unit shuffle triggers breakup concern
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content